Nymox Pharmaceutical Corporation (NYMX) Declined -6.82% or -0.12 To Price $1.64 On Monday


Nymox Pharmaceutical Corporation (NYMX) declined -6.82% or -0.12 to $1.64. It is near 61255 shares traded, which is 60.36% compare to the average total volume 101480. The market cap of NYMX is $104.50 million. The year to date change is -54.12%. The 52 week price range is from $1.49 to $4.6. Price of NYMX have changed -3.83% during last week. It have changed -5.38% over last month, -33.33% over last 3 months, -49.57% over last 6 months and -48.54% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NYMX is 1.97. It is 20.12% above current price. The 200-day Moving Averages for NYMX is 3.09. It is 88.41% above current price. The 52-week High is 4.6. It is 180.49% from the current price. The 52-week Low is 1.49. It is -9.15% from current price.

There are some statistics of NYMX. It is has market cap $104.50 million. The share outstanding is 63.72 million. The average volume is 101480. The percent of top 15 Institution holding is 10.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NYMX is -568.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NYMX is -340.42%.


Tags:

Share this post